Evaluation of the Diagnostic Potential of Artificial Intelligence-assisted Fecal Microbiome Testing for Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Microbiota, Colonoscopy
About this trial
This is an interventional diagnostic trial for Inflammatory Bowel Diseases focused on measuring Microbiome, Inflammatory bowel disease, Colonoscopy, Artificial intelligence, Screening test
Eligibility Criteria
Inclusion Criteria: being over 18 years of age not to be pregnant To apply with the complaint of chronic diarrhea (4 weeks or more) Not meeting any of the exclusion criteria Signing the voluntary consent form Exclusion Criteria: under 18 years old Pregnant or planning to become Acute diarrhea cases Have another known diagnosis of gastrointestinal disease ( malabsorption of any macronutrient, intestinal resection, celiac disease, etc.) Abdominal surgery other than appendectomy or hysterectomy history Psychiatric comorbidity Chronic disease that will affect the microbiome (cancer, diabetes, cardiovascular disease, liver diseases, neurological diseases, etc.) Use of drugs that may affect digestive function (including use in the last 4 weeks), probiotics, narcotic analgesics, lactulose (prebiotics) in the 4 weeks before the study Patients taking dietary supplements will not be included in the study.
Sites / Locations
- Medipol University Esenler HospitalRecruiting
Arms of the Study
Arm 1
Experimental
Colonoscopy
Fecal samples will be obtained from patients who are enrolled for colonoscopy procedure for the suspicion of inflammatory bowel disease